Archives of Clinical Infectious Diseases

Published by: Kowsar

Evaluation of Serum Level of Interleukin-6 in Patients With Crimean-Congo Hemorrhagic Fever in Zahedan, Iran, From 2012 to 2015

Seyed Mohammad Hashemi Shahri 1 , Javid Dehghan 1 , Zakaria Bameri 1 , Abdolhadi Kor 1 , Batool Sharifi Mood 1 , * and Masoud Mardani 2
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
2 Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: July 01, 2016, 11 (3); e28029
  • Published Online: June 26, 2016
  • Article Type: Research Article
  • Received: February 17, 2015
  • Revised: May 16, 2016
  • Accepted: May 29, 2016
  • DOI: 10.5812/archcid.28029

To Cite: Hashemi Shahri S M, Dehghan J, Bameri Z, Kor A, Sharifi Mood B, et al. Evaluation of Serum Level of Interleukin-6 in Patients With Crimean-Congo Hemorrhagic Fever in Zahedan, Iran, From 2012 to 2015, Arch Clin Infect Dis. 2016 ; 11(3):e28029. doi: 10.5812/archcid.28029.

Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Keshtkar-Jahromi M, Sajadi MM, Ansari H, Mardani M, Holakouie-Naieni K. Crimean-Congo hemorrhagic fever in Iran. Antiviral Res. 2013; 100(1): 20-8[DOI][PubMed]
  • 2. Sharifi-Mood B, Metanat M, Alavi-Naini R. Prevalence of crimean-congo hemorrhagic Fever among high risk human groups. Int J High Risk Behav Addict. 2014; 3(1)[DOI][PubMed]
  • 3. Sharifi-Mood B, Mardani M, Keshtkar-Jahromi M, Rahnavardi M, Hatami H, Metanat M. Clinical and epidemiologic features of Crimean-Congo hemorrhagic fever among children and adolescents from southeastern Iran. Pediatr Infect Dis J. 2008; 27(6): 561-3[DOI][PubMed]
  • 4. Sharifi-Mood B, Metanat M, Ghorbani-Vaghei A, Fayyaz-Jahani F, Akrami E. The Outcome of Patients with Crimean-Congo Hemorrhagic Fever in Zahedan, southeast of Iran: A Comparative Study . Arch Iranian Med. 2009; 12(2)
  • 5. Hashemi-Shahri S, Sharifi-Mood B, Metant M. Risk Factors Associated With Poor Prognosis in Children With Crimean-Congo Hemorrhagic Fever. Int J Infect. 2014; 1(3): 7-12
  • 6. Chinikar S. An overview of Crimean-Congo Hemorrhagic Fever in Iran. Iranian J Microbiol. 2009; 1(1): 7-12
  • 7. Mardani M, Rahnavardi M, Rajaeinejad M, Naini KH, Chinikar S, Pourmalek F, et al. Crimean-Congo hemorrhagic fever among health care workers in Iran: a seroprevalence study in two endemic regions. Am J Trop Med Hyg. 2007; 76(3): 443-5[PubMed]
  • 8. Mardani M, Keshtkar-Jahromi M, Ataie B, Adibi P. Crimean-Congo hemorrhagic fever virus as a nosocomial pathogen in Iran. Am J Trop Med Hyg. 2009; 81(4): 675-8[DOI][PubMed]
  • 9. Chinikar S, Ghiasi SM, Moradi M, Goya MM, Shirzadi MR, Zeinali M, et al. Geographical distribution and surveillance of Crimean-Congo hemorrhagic fever in Iran. Vector Borne Zoonotic Dis. 2010; 10(7): 705-8[DOI][PubMed]
  • 10. Keshtkar Jahromi M. Crimean-Congo Hemorrhagic Fever-Treatment and Preventive Strategies. Int J Infect. 2014; 1(2)
  • 11. Anderson R, Wang S, Osiowy C, Issekutz AC. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J Virol. 1997; 71(6): 4226-32[PubMed]
  • 12. Schnittler HJ, Feldmann H. Viral hemorrhagic fever--a vascular disease? Thromb Haemost. 2003; 89(6): 967-72[DOI][PubMed]
  • 13. Madonna R, Pandolfi A, Massaro M, Consoli A, De Caterina R. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia. 2004; 47(3): 532-6[DOI][PubMed]
  • 14. Connolly-Andersen AM, Moll G, Andersson C, Akerstrom S, Karlberg H, Douagi I, et al. Crimean-Congo hemorrhagic fever virus activates endothelial cells. J Virol. 2011; 85(15): 7766-74[DOI][PubMed]
  • 15. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis. 2006; 193(7): 941-4[DOI][PubMed]
  • 16. Sancakdar E, Guven AS, Uysal EB, Kaya A, Deveci K, Karapinar H, et al. Evaluation of cytokines as Th1/Th2 markers in pathogenesis of children with Crimean-Congo hemorrhagic fever. Int J Clin Exp Med. 2014; 7(3): 751-7[PubMed]
  • 17. Kaya S, Elaldi N, Kubar A, Gursoy N, Yilmaz M, Karakus G, et al. Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-alpha, IL-6, IL-10, and IFN-gamma levels in patients with Crimean-Congo hemorrhagic fever. BMC Infect Dis. 2014; 14: 416[DOI][PubMed]
  • 18. Deveci K, Oflaz MB, Sancakdar E, Uysal EB, Guven AS, Kaya A, et al. Evaluation of the serum levels of soluble IL-2 receptor and endothelin-1 in children with Crimean-Congo hemorrhagic fever. APMIS. 2014; 122(7): 643-7[DOI][PubMed]
  • 19. Ozsurekci Y, Arasli M, Karadag Oncel E, Caglayik DY, Kaya A, Icagasioglu FD, et al. Can the mild clinical course of crimean-congo hemorrhagic fever in children be explained by cytokine responses? J Med Virol. 2013; 85(11): 1955-9[DOI][PubMed]
  • 20. Dokuzoguz B, Celikbas AK, Gok SE, Baykam N, Eroglu MN, Ergonul O. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality. Clin Infect Dis. 2013; 57(9): 1270-4[DOI][PubMed]
  • 21. Bakhtiari K, Meijers JC, de Jonge E, Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med. 2004; 32: 2416-21
  • 22. Bente DA, Alimonti JB, Shieh WJ, Camus G, Stroher U, Zaki S, et al. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J Virol. 2010; 84: 11089-100
  • 23. Bakir M, Engin A, Gozel MG, Elaldi N, Kilickap S, Cinar Z. A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever. J Vector Borne Dis. 2012; 49(2): 105-10[PubMed]
  • 24. Cevik MA, Erbay A, Bodur H, Eren SS, Akinci E, Sener K, et al. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin Infect Dis. 2007; 45(7)-100[DOI][PubMed]
  • 25. Dewi BE, Takasaki T, Kurane I. Peripheral blood mononuclear cells increase the permeability of dengue virus-infected endothelial cells in association with downregulation of vascular endothelial cadherin. J Gen Virol. 2008; 89: 642-52[DOI][PubMed]
  • 26. Papa A, Bino S, Velo E, Harxhi A, Kota M, Antoniadis A. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol. 2006; 36(4): 272-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments